Group 1 - The Ministry of Commerce has issued the third batch of best practice cases for the national service industry expansion pilot, focusing on replicable and promotable experiences for service industry development [1] - The best practices include 11 innovative measures across three areas: industrial ecosystem construction, international cooperation, and regional collaboration [1] - The measures reflect collaborative openness and integrated innovation in key industries such as culture, technology, and healthcare [1] Group 2 - The State Administration for Market Regulation is soliciting public opinions on the revised draft regulations to curb the abuse of administrative power that restricts competition [2] - The National Bureau of Statistics reported that the average annual salary for urban non-private and private sector employees in 2024 will be CNY 124,110 and CNY 69,476, respectively [2] Group 3 - The Ministry of Finance and the Financial Regulatory Bureau have announced a push for the digitalization of bank confirmations to enhance efficiency and security [3] - The notification emphasizes the importance of increasing the number of entities accessing the bank confirmation platform [3] Group 4 - The Ministry of Commerce and the National Development and Reform Commission have revised the "Catering Industry Promotion and Management Measures," adding provisions to encourage international cooperation and digital development [4] - The revised measures include 25 articles aimed at promoting high-quality development in the catering industry [4] Group 5 - The State-owned Assets Supervision and Administration Commission announced personnel changes in 10 central enterprises, including leadership appointments and removals [5][6] Group 6 - The China Securities Regulatory Commission encourages private equity funds to participate in mergers and acquisitions of listed companies, with adjustments to lock-up periods for investments [7] - The Shenzhen Stock Exchange is monitoring stocks with abnormal price fluctuations, including "ST Yushun" and "ST Jiajia" [8] Group 7 - The Shenzhen Stock Exchange will host the 2025 Global Investor Conference to showcase the investment value of Chinese assets and the A-share market [9] Group 8 - The Ministry of Industry and Information Technology is accelerating the development of 5G-A and 6G technologies to support modern industrial systems [13] - The National Data Bureau aims for the core value added of the digital economy to exceed 10% of GDP by the end of 2025 [14] Group 9 - The Ministry of Industry and Information Technology reported that China has built the world's largest and most advanced information and communication network, with 5G applications covering 86 of 97 national economic categories [15] Group 10 - Binhai Energy plans to acquire 100% equity of Cangzhou Xuyang Chemical Co., Ltd., with the stock expected to resume trading on May 19, 2025 [17] - The automotive industry is set to benefit from a significant release of funds due to a recent reserve requirement ratio cut, potentially exceeding CNY 1 trillion [18] Group 11 - Xiaomi's President revealed that products using the self-developed "Xuanjie" chip will extend beyond smartphones [21] - Huamin Co. and Tiantai Robotics signed a strategic cooperation agreement to advance the robotics industry [21] Group 12 - Xiangzi High-Tech announced the sale of an 80% stake in Heilongjiang Yunfeng Automobile Co., Ltd. for CNY 24.6 million, aiming to restructure its fuel vehicle business [22] - ST Kexin has successfully removed its delisting risk warning and will change its stock name to Kexin Development [23] Group 13 - *ST Aonong has received approval to remove its delisting risk warning, with its stock name changing to Aonong Biological [24][25] - Jianghan New Materials plans to repurchase shares worth CNY 200 million to CNY 400 million [26] Group 14 - Siyuan Electric intends to repurchase shares worth CNY 300 million to CNY 500 million [27] - Liren Lizhuang reported that products containing "Mikang Sulfur" have a minimal impact on overall business performance [28] Group 15 - Jinhe Biological's controlling shareholder plans to reduce its stake by up to 3% [29] - Guanghui Energy announced the transfer of 15.03% of its shares to two insurance companies [30] Group 16 - Tailing Microelectronics reported a reduction in the National Big Fund's shareholding to 6.95% [31] - AVIC High-Tech plans to invest CNY 918 million to enhance its capabilities in aviation composite materials [32]

Group 1 - The domestic production of adiponitrile is accelerating, and the demand for civilian silk is expected to be released, indicating a broad growth space for nylon 66 (PA66) [1] - Currently, the application ratio of nylon 66 in civilian silk is low (13%), but successful breakthroughs in civilian silk technology could partially replace the nylon 6 market, which had a consumption of 4.35 million tons in 2023 [1] - China's reliance on imports of adiponitrile from the US has been high, with US companies holding a significant share of global production capacity, leading to potential price fluctuations due to trade tensions [1][2] Group 2 - Invista's adiponitrile production capacity in Shanghai is primarily for internal supply, limiting external sales, while the domestic project by China Chemical has successfully overcome technical barriers [2] - The production cost of adiponitrile is approximately 11,600 yuan per ton, with key raw materials including butadiene, natural gas, and liquid ammonia [2] - The project by China Chemical is expected to benefit from the acceleration of domestic adiponitrile replacement and increased demand for civilian silk [2] Group 3 - The profitability of the adiponitrile project is projected to be strong, with break-even prices estimated at 17,700 yuan per ton at 150% capacity utilization and 19,000 yuan per ton at 100% utilization [3] - The average price of domestic adiponitrile since May has been around 22,200 yuan per ton, close to the break-even line at 50% capacity utilization [3] - The projected net profits for the company from 2025 to 2027 are expected to grow by 12.7%, 13.4%, and 11.2% respectively, with current price-to-earnings ratios of 7.5, 6.6, and 6.0 times [3] Group 4 - The company is recommended for continued focus due to significant earnings elasticity from industrial projects, accelerated execution of overseas contracts, and strong cash flow [4]

Investment Rating - The investment rating for the company is "Buy" [4] Core Views - The domestic production of adiponitrile is accelerating, and the demand for civilian nylon is expected to be released, indicating a broad growth space in the future. Nylon 66, one of the most widely used nylon products, has a low application ratio in civilian yarns (13%), which could potentially replace the nylon 6 market if technological breakthroughs occur [1][12] - The company has successfully overcome significant technical barriers in adiponitrile production, making it the first project in China with independent intellectual property rights to produce adiponitrile on a large scale using the direct hydrogenation method [1][12] - The project is expected to benefit from the acceleration of domestic adiponitrile production and the increase in demand for civilian yarns [1][12] Summary by Sections Production Cost and Profitability - The estimated cost of producing adiponitrile is approximately 11,600 CNY per ton, with the main raw materials being butadiene, natural gas, and liquid ammonia [2][16] - The break-even price for the company's adiponitrile project is estimated at 17,700 CNY per ton at 150% capacity utilization and 19,000 CNY per ton at 100% capacity utilization [3][17] - The projected net profit for the company is expected to be 3.62 billion CNY at full capacity and 7.64 billion CNY after technical upgrades [3][19] Financial Projections - The company’s projected net profits for 2025-2027 are 6.4 billion, 7.3 billion, and 8.1 billion CNY, respectively, with year-on-year growth rates of 12.7%, 13.4%, and 11.2% [3][19] - The current price-to-earnings (P/E) ratios for the years 2025, 2026, and 2027 are estimated at 7.5, 6.6, and 6.0 times, respectively [3][19] Market Context - The global capacity for adiponitrile production is currently dominated by American companies, with significant reliance on imports. The domestic market is expected to shift towards local production to ensure supply chain security [1][12] - The company is well-positioned to capitalize on the increasing domestic demand and the potential for market share growth in the nylon 66 sector [1][12]

Core Viewpoint - The signing of the EPC contract for the Aktyubinsk Ferroalloy Plant flue gas power generation project marks a significant milestone in the collaboration between China Chemical Tianchen Company and Kazakhstan's ERG Group, representing the first flue gas recovery power generation project in Central Asia, emphasizing innovative environmental technology and substantial emission reduction benefits [2][3]. Group 1 - The project will utilize Tianchen Company's efficient green flue gas recovery power generation technology to recycle production flue gas from the ERG Group's Aktyubinsk Ferroalloy Plant, enabling power generation [2]. - Upon completion, the project is expected to save approximately 200 million standard cubic meters of natural gas annually and reduce carbon dioxide emissions by 320,000 tons, contributing to energy utilization efficiency and significantly lowering electricity costs for the enterprise [2]. - The project is recognized as a key initiative in Kazakhstan's green power sector, supporting the country's energy conservation and emission reduction goals while promoting sustainable economic development [2]. Group 2 - The successful implementation of the Aktyubinsk Ferroalloy Plant flue gas power generation project exemplifies Tianchen Company's innovative "T+EPC" business model, leveraging its advantages in flue gas recovery technology and engineering contracting experience [3]. - This project is expected to bring significant economic and environmental benefits to Kazakhstan and establish a benchmark for green energy engineering in the region, showcasing the core competitiveness of "China Chemical Intelligence Manufacturing" [3]. - The project will provide strong momentum for China Chemical's entry into the global high-end engineering market and serves as a vivid representation of the win-win cooperation between China and Kazakhstan under the "Belt and Road" initiative [3].

Investment Rating - The report maintains a "Positive" outlook for the building materials industry [2] Core Insights - The building materials sector continues to experience historical lows in 2024 and 2025, but signs of improvement are emerging [4][12] - Revenue for the building materials sector in 2024 is projected at CNY 682.93 billion, a year-on-year decline of 12.41%, ranking second to last among 31 industries [4][16] - In Q1 2025, the sector's revenue decline narrowed to 1.60%, with a revenue of CNY 129.83 billion, improving its ranking to 18th among industries [5][40] - The net profit margin and return on equity (ROE) are at historical lows, with the sector's net profit margin dropping to 2.61% in 2024 [25][28] Summary by Sections 1. Industry Performance Overview - The building materials sector's revenue and net profit continue to decline in 2024, remaining at the bottom of industry rankings [4][16] - Q1 2025 shows a narrowing revenue decline and improvements in net profit and cash flow, with a net profit of -CNY 243 million, a 74.02% year-on-year increase [5][44] 2. Segment Performance - In Q1 2025, segments like cement and glass fiber show positive revenue growth, with cement revenue up 0.11% and glass fiber up 25.24% [6][55] - Most segments, except for pipes, show improvements in net profit year-on-year, with cement, glass fiber, refractory materials, and coatings ending their respective revenue declines [6][58] 3. Investment Strategy - The report suggests that leading companies in the sector can achieve better growth in a challenging environment through internal and external development strategies [8][81] - The anticipated recovery of the real estate sector is expected to stabilize demand for building materials, leading to valuation recovery in the industry [8][84] - Recommended companies include Beixin Building Materials, Weixing New Materials, Shandong Pharmaceutical Glass, and others [8][84]

【导读】中国化学（601117）孙公司涉康得新证券虚假陈述责任纠纷诉讼 5月15日，中国化学工程股份有限公司（以下简称中国化学）发布公告称，孙公司中国化学赛鼎宁波工程有限公司（以下简称赛鼎 宁波）近日收到江苏省苏州市中级人民法院送达的《应诉通知书》，获悉赛鼎宁波涉及浙江中泰创赢资产管理有限公司（以下简称 中泰创赢）起诉康得新复合材料集团股份有限公司（以下简称康得新）证券虚假陈述责任纠纷诉讼。 中国化学表示，经初步核实，赛鼎宁波不存在明知康得新实施财务造假而依然配合的情形。 公告显示，中国化学孙公司赛鼎宁波近日收到江苏省苏州市中级人民法院送达的《应诉通知书》。 原告中泰创赢称，其于2016年11月起持续投资购买康得新股票，截至2021年5月减持完毕，上述投资发生损失。原告中泰创赢请求 法院判令被告一（康得新）支付因其虚假陈述造成的投资差额损失约51.47亿元，投资差额损失部分的佣金约154.42万元，印花税约 514.73万元。另有十位其他被告。 赛鼎宁波是共同被告中的第七被告。原告中泰创赢称，除被告一外，赛鼎宁波等十位被告在本案中对原告应承担的给付义务承担连 带赔偿责任。 截至5月15日收盘，中国化学股价报8 ...

Core Viewpoint - China Chemical (601117.SH) announced that its subsidiary, China Chemical Sading Ningbo Engineering Co., Ltd., is involved in a lawsuit concerning securities fraud against Kangde Xin Composite Materials Group Co., Ltd. [1][3] Group 1: Lawsuit Details - Zhejiang Zhongtai Chuangying Asset Management Co., Ltd. claims investment losses of 5.147 billion yuan due to Kangde Xin's false statements from 2016 to 2021 and seeks compensation, including related commissions and taxes [3] - Sading Ningbo is listed as the seventh defendant in the lawsuit, primarily due to previous business dealings with Kangde Xin, but the company asserts it did not knowingly assist in any fraudulent activities [3][4] - The case involves eleven defendants, and China Chemical preliminarily assesses that it will not materially impact current or future profits [3][4] Group 2: Background on Kangde Xin - Kangde Xin was listed in July 2010 and specializes in the research and consulting of polymer composite materials and functional film materials [4] - The company was forced to delist in 2021 after it was found to have fabricated over 10 billion yuan in profits [4] - Zhejiang Zhongtai Chuangying became the second-largest shareholder of Kangde Xin after signing a strategic cooperation agreement in 2016, which was terminated in 2018 [4]

Group 1: Company Announcements - Heng Rui Pharmaceutical has completed its share repurchase plan, spending approximately 600 million yuan, repurchasing 12.9051 million shares, which is 0.20% of the total share capital, with an average repurchase price of about 46.59 yuan per share [1] - Chengdi Xiangjiang's wholly-owned subsidiary signed an EPC general contracting contract with China Mobile for a project worth 1.632 billion yuan, which is expected to positively impact future revenue [2] - Jingyuan Environmental Protection's wholly-owned subsidiary signed a contract for a computing cluster construction project worth 365 million yuan, with a gross profit margin of approximately 9% to 10% [3] Group 2: Legal and Regulatory Issues - China Chemical's subsidiary is involved in a lawsuit concerning false statements related to securities, with a claim for damages amounting to 5.147 billion yuan [4] - ST Huijin has applied to revoke its other risk warning status after addressing issues from a previous administrative penalty, pending approval from the Shenzhen Stock Exchange [5] Group 3: Stock Performance and Risks - Ningbo Shipping's stock has seen a significant short-term increase, with a cumulative price deviation exceeding 20% over three trading days, indicating potential trading risks [6] - Lianyungang's stock has also experienced a similar short-term price increase, with a 48.01% year-on-year decline in net profit for the first quarter [7] - Xinhua Jin has reported potential risks of administrative penalties or disciplinary actions from the China Securities Regulatory Commission due to uncertainties in export business [8]

Group 1 - Feilong Co., Ltd. received a project designation notification letter from a well-known domestic automobile brand, becoming a supplier for a water-side thermal management module, with expected sales revenue during the lifecycle meeting disclosure standards [1] - Hanchuan Intelligent's controlling shareholder received a warning letter from Jiangsu Securities Regulatory Bureau for failing to timely disclose a share pledge contract, which may affect the company's control and stock price [2] - Vanke A completed the redemption of the "20 Vanke 04" corporate bonds, with a redemption amount of 1.5 billion yuan and interest payment of 51.75 million yuan [3][4] Group 2 - China Shenhua reported a 4% year-on-year decline in coal sales volume for April, totaling 35.6 million tons, and a 3.9% decrease in commodity coal production [5] - Shaanxi Black Cat plans to increase capital by 600 million yuan for its wholly-owned subsidiary Xinjiang Black Cat Coal Industry to enhance its capital strength [6][7] - China National Aviation reported an 8.6% year-on-year increase in passenger turnover for April, with a 5.3% increase in passenger capacity [8][9] Group 3 - Huabei Pharmaceutical's subsidiary received approval for clinical trials of a recombinant tetanus vaccine, which is a new generation vaccine with better safety and immunogenicity [10] - China Chemical's subsidiary received a lawsuit notice related to a securities false statement liability dispute [11] - China Metallurgical Group reported a 24.9% year-on-year decline in new contract value for January to April, totaling 308.4 billion yuan [13] Group 4 - Zhongmei Energy reported a 5.8% year-on-year decline in commodity coal sales for April, totaling 21.1 million tons [14] - Huangma Technology announced a plan to reduce holdings of up to 6.26 million shares due to personal funding needs [15] - Aiyingshi proposed a cash dividend of 2.53 yuan per 10 shares for the fiscal year 2024 [16] Group 5 - Shengyi Technology's executives plan to reduce their holdings by a total of 1.49 million shares [17] - CanSino's inhaled tuberculosis vaccine received clinical trial approval in Indonesia [18] - Beidouxingtong completed the acquisition of 51% of Shenzhen Tianli Automotive Electronics Technology Co., Ltd. [19] Group 6 - Spring Airlines reported a 12.29% year-on-year increase in available capacity for April, with a total of 4.73 billion ton-kilometers [20] - Dongya Pharmaceutical's raw material drug received registration certification in South Korea [21] - Shandong Steel plans to establish a sales subsidiary with a registered capital of 20 million yuan [22] Group 7 - Caida Securities appointed Hu Hengsong as the executive vice president [23] - Aibulu's vice president resigned due to personal career planning [24] - *ST Jinguang's stock price surged amid a warning of delisting risk [25] Group 8 - Yunnan Energy Investment plans to implement a 600,000 tons/year salt production energy-saving and carbon reduction project with a total investment of 448 million yuan [27] - Hanyu Group's executives plan to reduce their holdings due to personal funding needs [28] - Jiangsu Boyun's shareholders plan to reduce their holdings by up to 971,300 shares [29] Group 9 - Hainan Airport signed a cooperation agreement with Harbin Institute of Technology (Shenzhen) to establish a joint laboratory [32] - Xiamen Tungsten New Energy plans to acquire 47% of Ganzhou Haopeng Technology Co., Ltd. [33] - Dongfang Materials announced a change in controlling shareholder due to judicial auction of shares [34] Group 10 - Jingyuan Environmental Protection's executives plan to reduce their holdings by a total of 1.176% of the company's shares [35] - China Pacific Insurance reported a 10.4% year-on-year increase in original insurance premium income for the first four months [36] - ST United is planning a major asset restructuring and has suspended trading [37] Group 11 - *ST Suwu's chairman received a notice of investigation for suspected information disclosure violations [39] - Huagong Technology's subsidiary plans to establish a joint venture [40] - Qibin Group terminated the purchase of 28.78% equity in its subsidiary [41] Group 12 - Huakang Clean signed a construction contract worth 143 million yuan with Dengfeng City General Hospital [42] - Kanghong Pharmaceutical received approval for clinical trials of a drug for postpartum depression [43] - Shengjing Micro plans to repurchase shares worth between 30 million and 50 million yuan [44] Group 13 - Shenghe Resources' subsidiary plans to acquire 100% of Peak Rare Earths Limited for 158 million Australian dollars [45] - Sinopec's controlling shareholder increased its stake by 302 million H-shares, amounting to HKD 1.232 billion [46] - Mingyang Circuit plans to repurchase shares worth between 15 million and 25 million yuan [47] Group 14 - China Oil Engineering's subsidiary won a project in Iraq worth approximately 11.538 billion yuan [48] - Chaojie Co., Ltd. announced the termination of a share transfer agreement [49]

一、本次诉讼的基本情况 证券代码：601117 股票简称：中国化学 公告编号：临 2025-020 中国化学工程股份有限公司 1.管辖法院：苏州市中级人民法院 关于孙公司收到应诉通知书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误 导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法 律责任。 重要内容提示： 中国化学工程股份有限公司（以下简称"公司"）孙公司中国 化学赛鼎宁波工程有限公司（以下简称"赛鼎宁波"）近日收到江 苏省苏州市中级人民法院送达的《应诉通知书》，获悉赛鼎宁波涉 及浙江中泰创赢资产管理有限公司（以下简称"中泰创赢"）起诉 康得新复合材料集团股份有限公司（以下简称"康得新"）证券虚 假陈述责任纠纷诉讼。本案曾于 2022 年在南京市中级人民法院立案， 现移送至苏州市中级人民法院受理，系存量案件，仅涉及管辖法院 变更，诉讼请求等未发生变化。截至本公告日，该诉讼事项尚未开 庭审理。 1 案件所处的诉讼阶段：法院已立案受理，尚未开庭审理。 公司下属孙公司所处的当事人地位：共同被告（第七被告）。 2.原告：浙江中泰创赢资产管理有限公司 3.被告： 被告一：康得新复合材料 ...